Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
Explore more from The Transmitter
A consensus on the definition of profound autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 July.
A consensus on the definition of profound autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 July.
‘Completely new learning mechanism’ drives navigation in fruit flies
The neuromodulator octopamine, the insect counterpart to norepinephrine, helps flies get their bearings in an unfamiliar environment.
‘Completely new learning mechanism’ drives navigation in fruit flies
The neuromodulator octopamine, the insect counterpart to norepinephrine, helps flies get their bearings in an unfamiliar environment.
How to use artificial intelligence to strengthen scientific processes and scholarly output
As AI-driven systems are integrated into all aspects of science, we need to make sure that they read and write to a shared data and knowledge space.
How to use artificial intelligence to strengthen scientific processes and scholarly output
As AI-driven systems are integrated into all aspects of science, we need to make sure that they read and write to a shared data and knowledge space.